Toxoplasma gondii infection is widespread worldwide, not only posing a serious threat to human food safety and animal husbandry, but also endangering human health. The selectivity index was employed to measure anti-T. gondii activity. Hederagenin (HE) exhibited potent anti-T. gondii activity and low cytotoxicity. For this reason, HE was selected for in vivo experiments. HE showed 64.8%±13.1% inhibition for peritoneal tachyzoites in mice, higher than spiramycin 56.8%±6.0%. Biochemical parameters such as alanine aminotransferase, aspartate aminotransferase, glutathione, and malondialdehyde, illustrated that HE was a good inhibitor of T. gondii in vivo. This compound was also effective in relieving T. gondii-induced liver damage. Collectively, it was demonstrated that HE had potential as an anti-T. gondii agent.
Citations
Citations to this article as recorded by
Daflon illuminates a novel avenue in treating acute toxoplasmosis: An experimental study Nahla El Skhawy, Aceel Y. Hassan, Sarah Ahmed Hassan, Hala E. Diab Veterinary Parasitology.2026; 345: 110788. CrossRef
Could Fluoxetine Confer a Favourable Immuno‐Inflammatory Profile in a Murine Model of Acute Toxoplasmosis? Wesam M. A. Elgendy, Ahmad A. Othman, Basma N. Khalifa, Nema A. Soliman, Dareen Mohamed, Salwa S. Younis Parasite Immunology.2026;[Epub] CrossRef
Repurposing the proton pump inhibitor "Rabeprazole sodium" in the treatment of acute experimental murine toxoplasmosis Maha Mohamed Gomaa, Hayam Abdel Moneim Sadaka, Hadeer Elsayed Abdelmoneam Hussien, Nourhan Mohamed Kolaib, Hoda Adel Rashed Acta Tropica.2026; 281: 108242. CrossRef
An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives Huize Zhang, Yong Li, Yi Liu Frontiers in Pharmacology.2024;[Epub] CrossRef
Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives Siyang Liu, Minghao Cai, Zhendi Liu, Weixin Gao, Junjie Li, Yuxueqing Li, Xiayire Abudouxukuer, Jili Zhang Journal of Medicinal Chemistry.2024; 67(23): 20740. CrossRef
Sulfadiazine analogs: anti-Toxoplasma in vitro study of sulfonamide triazoles Fadwa M Arafa, Doaa Hassan Osman, Mona Mohamed Tolba, Nadjet Rezki, Mohamed R Aouad, Mohamed Hagar, Mervat Osman, Heba Said Parasitology Research.2023; 122(10): 2353. CrossRef
Synthesis and evaluation of
in vitro
and
in vivo
anti
-Toxoplasma gondii
activity of tetraoxane-substituted ursolic acid derivatives
Ya-Lan Wang, Li-Li Jin, Xu Cheng, Wei-Feng Yan, Hao Deng, Qing-Kun Shen, Zhe-Shan Quan, Chun-Mei Jin, Chang-Hao Zhang Natural Product Research.2023; 37(21): 3654. CrossRef
Pharmacological overview of hederagenin and its derivatives Xing Huang, Qing-Kun Shen, Hong-Yan Guo, Xiaoting Li, Zhe-Shan Quan RSC Medicinal Chemistry.2023; 14(10): 1858. CrossRef
Synthesis and Antitumor Activity of Hederagenin Derivatives Xing Huang, Changhao Zhang, Hao Deng, Qingkun Shen, Hongyan Guo, Zheshan Quan, Zhiyong Li, Lili Jin Chinese Journal of Organic Chemistry.2022; 42(9): 2877. CrossRef
First
Prev
